No connection

Search Results

PG

BEARISH
$145.71 Live
The Procter & Gamble Company · NYSE
Target $163.27 (+12.1%)
$137.62 52W Range $170.99

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 24, 2026
Market cap
$340.49B
P/E
21.59
ROE
31.6%
Profit margin
19.3%
Debt/Equity
0.69
Dividend yield
2.92%

AI Analysis

AI-powered fundamental assessment

Confidence
85%
PG exhibits a stable financial foundation with a Piotroski F-Score of 6/9, but it is severely overvalued relative to its deterministic baselines. The current price of $145.71 represents a massive premium over the Graham Number ($58.45) and Intrinsic Value ($47.25), while a PEG ratio of 3.92 indicates the valuation is disconnected from its stagnant growth. Negative earnings growth (-5.40% YoY) combined with bearish insider activity and a 0/100 technical trend suggests significant downside risk despite the company's operational efficiency.

Key Strengths

Exceptional Return on Equity (ROE) of 31.56%
Strong gross margins (51.19%) and operating margins (26.30%)
Consistent track record of beating earnings estimates over 25 quarters
Stable financial health as indicated by a Piotroski F-Score of 6/9
Dominant market position in the Consumer Defensive sector

Key Risks

Extreme valuation premium over Graham and Intrinsic value estimates
Negative earnings growth (-5.40% YoY and -6.70% Q/Q)
Weak liquidity ratios with a Current Ratio of 0.72 and Quick Ratio of 0.47
Bearish insider sentiment with $55.46M in net sales and zero buys
Stagnant revenue growth (1.50% YoY) limiting future upside
AI Fair Value Estimate
Based on comprehensive analysis
$72.5
-50.2% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
52
Moderate
Value
20
Future
30
Past
85
Health
65
Dividend
60
AI Verdict
Overvalued Quality
Key drivers: Severe valuation gap, Negative earnings growth, Strong operational margins, Bearish technicals/insiders
Confidence
90%
Value
20/100

Ref P/E 21.59, PEG 3.92, Graham Number $58.45

Positives
  • P/E is lower than sector average
Watchpoints
  • Price is ~150% above Graham Number
  • PEG ratio of 3.92 is excessively high
  • Price/Book of 6.48 is steep
Future
30/100

Ref Growth rates

Positives
  • Slight positive revenue growth
Watchpoints
  • Negative YoY earnings growth (-5.40%)
  • Negative Q/Q earnings growth (-6.70%)
Past
85/100

Ref Historical trends

Positives
  • Consistent earnings beats (3/4 last 4)
  • Long-term stability in earnings delivery
Watchpoints
  • 1-year price performance is negative (-10.2%)
Health
65/100

Ref Piotroski F-Score, Current Ratio

Positives
  • Piotroski F-Score 6/9 (Stable)
  • Manageable Debt/Equity (0.69)
Watchpoints
  • Current Ratio (0.72) indicates potential short-term liquidity pressure
Dividend
60/100

Ref Yield 2.92%, Payout 61.88%

Positives
  • Consistent dividend yield of 2.92%
Watchpoints
  • Payout ratio of 61.88% limits aggressive growth in dividends

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$145.71
Analyst Target
$163.27
Upside/Downside
+12.1%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for PG and closest competitors.

Updated 2026-04-23
PG
The Procter & Gamble Company
Primary
5Y
+25.1%
3Y
-0.0%
1Y
-10.2%
6M
-2.9%
1M
+1.8%
1W
+1.8%
KO
The Coca-Cola Company
Peer
5Y
+63.4%
3Y
+28.6%
1Y
+8.1%
6M
+9.2%
1M
-0.4%
1W
-0.1%
PM
Philip Morris International Inc.
Peer
5Y
+153.1%
3Y
+89.2%
1Y
+25.8%
6M
-7.3%
1M
-1.5%
1W
+1.3%
COS
Costco Wholesale Corporation
Peer
5Y
+196.5%
3Y
+108.9%
1Y
+5.9%
6M
+8.0%
1M
-0.6%
1W
+2.3%
PEP
PepsiCo, Inc.
Peer
5Y
+25.4%
3Y
-7.1%
1Y
+12.8%
6M
+4.4%
1M
-1.8%
1W
+0.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
21.59
Forward P/E
20.23
PEG Ratio
3.92
P/B Ratio
6.48
P/S Ratio
3.99
EV/Revenue
4.29
EV/EBITDA
14.76
Market Cap
$340.49B

Profitability

Profit margins and return metrics

Profit Margin 19.3%
Operating Margin 26.3%
Gross Margin 51.19%
ROE 31.56%
ROA 10.9%

Growth

Revenue and earnings growth rates

Revenue Growth +1.5%
Earnings Growth -5.4%
Q/Q Revenue Growth +1.49%
Q/Q Earnings Growth -6.7%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.69
Moderate
Current Ratio
0.72
Weak
Quick Ratio
0.47
Poor
Cash/Share
$4.66

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$22.2B
Gross Margin
51.2%
Op. Margin
24.2%
Net Margin
19.4%
Total Assets
$127.3B
Liabilities
$74.0B
Equity
$53.0B
Debt/Equity
1.39x
Operating CF
$5.0B
CapEx
$-1.2B
Free Cash Flow
$3.8B
FCF Yield
77%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-04-24
$N/A
2026-01-22
$1.88
+1.2% surprise
2025-10-24
$1.99
+4.9% surprise
2025-07-29
$1.48
+4.1% surprise

Consumer Defensive Sector Comparison

Comparing PG against 170 companies in the Consumer Defensive sector (9 bullish, 60 neutral, 101 bearish)
P/E Ratio
21.59
This Stock
vs
37.45
Sector Avg
-42.4% (Discount)
Return on Equity (ROE)
31.56%
This Stock
vs
-13.91%
Sector Avg
-326.8% (Below Avg)
Profit Margin
19.3%
This Stock
vs
-7.77%
Sector Avg
-348.3% (Weaker)
Debt to Equity
0.69
This Stock
vs
1.89
Sector Avg
-63.6% (Less Debt)
Revenue Growth
1.5%
This Stock
vs
111.74%
Sector Avg
-98.7% (Slower)
Current Ratio
0.72
This Stock
vs
2.29
Sector Avg
-68.4% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

MCCARTHY CHRISTINE M.
Director
Stock Award
2026-03-10
209 shares
PORTMAN ROBERT JONES
Director
Stock Award
2026-03-10
193 shares
PORTMAN ROBERT JONES
Director
Stock Award
2026-03-10
49 shares
MCEVOY ASHLEY
Director
Stock Award
2026-03-10
161 shares
KEMPCZINSKI CHRISTOPHER J
Director
Stock Award
2026-03-10
201 shares
JIMENEZ JOSEPH JR
Director
Stock Award
2026-03-10
273 shares
ARNOLD CRAIG
Director
Stock Award
2026-03-10
161 shares
FRANCISCO MA. FATIMA
Officer
Sell
2026-02-27
5,549 shares · $917,199
WHALEY SUSAN STREET
Officer
Sell
2026-02-19
1,809 shares · $288,454
AGUILAR MOSES VICTOR JAVIER
Officer
Sell
2026-02-13
15,169 shares · $2,461,609
AGUILAR MOSES VICTOR JAVIER
Officer
Option Exercise
2026-02-13
15,169 shares · $1,381,441
COOMBE GARY A
Officer
Sell
2026-02-12
36,093 shares · $5,859,002
COOMBE GARY A
Officer
Option Exercise
2026-02-12
36,093 shares · $2,834,022
MOELLER JON R
Officer and Director
Sell
2026-02-12
173,268 shares · $28,120,121
MOELLER JON R
Officer and Director
Option Exercise
2026-02-12
173,268 shares · $19,619,136
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

8-K
8-K
2026-04-14

Procter & Gamble filed an 8-K on April 14, 2026, likely reporting its third-quarter financial results.

10-Q
FY2526 Q2 OND 10-Q
2026-01-23

Procter & Gamble filed its Form 10-Q for the second quarter of fiscal year 2026 on January 23, 2026. While specific financial metrics were not provided in the excerpt, the filing includes a dedicated section on risk factors under Item 1A.

8-K
FY2526 Q2 OND 8-K
2026-01-22

Procter & Gamble filed an 8-K on January 22, 2026, to report its financial results for the second quarter of fiscal year 2026.

8-K
8-K
2026-01-22

Procter & Gamble announced its quarterly financial results.

8-K
8-K
2026-01-13

Procter & Gamble announced its quarterly financial results.

8-K
8-K
2025-12-15

Procter & Gamble filed an 8-K on December 15, 2025, likely to announce a quarterly dividend or report a material corporate update.

8-K
8-K
2025-11-04

Procter & Gamble filed an 8-K on November 4, 2025, likely to announce its quarterly financial results.

8-K
8-K
2025-11-03

Procter & Gamble likely reported its quarterly financial results in this 8-K filing.

10-Q
FY2526 Q1 JAS 10-Q
2025-10-24

Procter & Gamble (PG) filed its 10-Q for the first quarter of fiscal year 2026 on October 24, 2025. While specific financial metrics were not provided in the excerpt, the filing includes updated risk disclosures under Item 1A.

8-K
8-K
2025-10-24
8-K
FY2526 Q1 JAS 8-K
2025-10-24

Procter & Gamble filed an 8-K on October 24, 2025, to report its financial results for the first quarter of fiscal year 2026.

8-K
8-K
2025-10-16
8-K
8-K
2025-10-14
DEF 14A
DEF 14A
2025-08-29
8-K
8-K
2025-08-14
Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
22 analysts
JP Morgan
2026-04-17
Maintains
Overweight Overweight
Barclays
2026-04-14
Maintains
Equal-Weight Equal-Weight
B of A Securities
2026-04-10
Maintains
Buy Buy
Wells Fargo
2026-04-08
Maintains
Overweight Overweight
Piper Sandler
2026-04-08
Maintains
Neutral Neutral
UBS
2026-04-07
Maintains
Buy Buy
Deutsche Bank
2026-03-30
Maintains
Hold Hold
TD Cowen
2026-01-27
down
Buy Hold
UBS
2026-01-23
Maintains
Buy Buy
Wells Fargo
2026-01-23
Maintains
Overweight Overweight

Past News Coverage

Recent headlines mentioning PG from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile